Basic study on DNA vaccine in Hepatitis type C
Project/Area Number |
09670568
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Jichi Medical School |
Principal Investigator |
MORIYAMA Takashi Jichi Medical School, Department of Medicine, Assistant Professor, 医学部・分子免疫学研究室, 講師 (10240706)
|
Co-Investigator(Kenkyū-buntansha) |
KANEKO Takashi Jichi Medical School, Department of Medicine, Assistant, 医学部・分子免疫学研究室, 助手 (10254913)
|
Project Period (FY) |
1997 – 1998
|
Project Status |
Completed (Fiscal Year 1998)
|
Budget Amount *help |
¥3,300,000 (Direct Cost: ¥3,300,000)
Fiscal Year 1998: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1997: ¥2,800,000 (Direct Cost: ¥2,800,000)
|
Keywords | hepatitis C virus / DNA vaccine / cytotoxic T lymphocyte / adjuvant / アジュバント / 慢性肝炎 / 肝硬変 / 肝細胞癌 / C型肝炎ウイルス / 細胞障害性T細胞 / 免疫学 |
Research Abstract |
We tried to induce a T cell liesponse to hepatitic Cvirus (HCV) core protein by using a DNA vaccine in mice. We constructed plasmids encoding HCV core region under the control of various promotors such as pMAMneo, pEFBOS, and pcDNA3. These plasmids alone induced a helper T cell response only after in vitro restimulation twice. A cytotoxic Tlymphocyte (CTL) response was observed but the magnitude was not strong. Next we immunized mice with a plasmid encoding HCV core region together with an adjuvant plasmid encoding IL-2, GM-CSF, or (CD86. None of these combination resulted in a betterT cell response yet.
|
Report
(3 results)
Research Products
(12 results)